Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we highlight several significant developments, including RyboDyn's collaboration with Lilly Gateway Labs to advance immunotherapy research. In the realm of business and investments, Sword Health has secured €34.6 million to expand its AI-driven mental health solutions, while HOPPR has raised $31.5 million to enhance AI applications in medical imaging.
Additionally, RevelAi Health has garnered $3.1 million to innovate AI in musculoskeletal care. On the technology front, Infinitus Systems is expanding its partnership with Salesforce, and The SSI Group has unveiled new AI solutions at the HFMA 2025 conference. Stay tuned as we explore these stories and their implications for the future of healthcare technology.